Background: Allergic reactions to mosquito bites are an increasing clinical concern. Due to the lack of availability of mosquito salivary allergens, they are underdiagnosed. Here, we reported a newly cloned mosquito Aedes (Ae.) aegypti salivary allergen.
Methods: A cDNA encoding a 30-kDa Ae. aegypti salivary protein, designated Aed a 3, was isolated from an expression library. The full-length cDNA was cloned into a baculovirus expression vector, and recombinant Aed a 3 (rAed a 3) was expressed, purified, and characterized. Skin prick tests with purified rAed a 3 and Ae. aegypti bite tests were performed in 43 volunteers. Serum rAed a 3-specific IgE levels were measured in 28 volunteers.
Results: The primary nucleotide sequence, deduced amino acid sequence, and IgE-binding sites of Aed a 3 were identified. rAed a 3-selected antibodies recognized a 30-kDa Ae. aegypti saliva protein. rAed a 3 bound IgE in mosquito-allergic volunteers and the binding could be inhibited by the addition of natural mosquito extract dose dependently. Immediate skin test reactions to rAed a 3 correlated significantly with mosquito bite-induced reactions. Of the bite test-positive volunteers, 32% had a positive rAed a 3 skin test and 46% had specific IgE. No bite test-negative volunteers reacted to rAed a 3 in either the skin tests or the IgE assays, confirming the specificity of the assay.
Conclusions: Aed a 3 that corresponds to the Aegyptin protein is a major mosquito salivary allergen. Its recombinant form has biological activity and is suitable for use in skin tests and specific IgE assays in mosquito-allergic individuals.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844854 | PMC |
| http://dx.doi.org/10.1111/all.12812 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of human exposure to Anopheles and Aedes bites using antibody-based biomarkers in rural zone of Cameroon.
PLoS One
December 2024
Laboratory of Fundamental and Applied Entomology, University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
Malaria and Aedes-borne diseases remain major causes of mortality, morbidity, and disability in most developing countries. Surveillance of transmission patterns associated with vector control remains strategic for combating these diseases. Due to the limitions of current surveillance tools used to assess human exposure to mosquito bites, human antibody (Ab) responses to salivary peptides from Anopheles (gSG6-P1) and Aedes (Nterm-34kDa) are increasingly being used to measure direct human-Anopheles or Aedes contact.
View Article and Find Full Text PDFResearch progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases.
PLoS Negl Trop Dis
December 2024
Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Hematophagous arthropods, including mosquitoes, ticks, and flies, are responsible for the transmission of several pathogens to vertebrates on whom they blood feed. The diseases caused by these pathogens, collectively known as vector-borne diseases (VBDs), threaten the health of humans and animals. In general, attempts to develop vaccines for pathogens transmitted by arthropods have met with moderate success, with few vaccine candidates currently developed.
View Article and Find Full Text PDFIn the first quarter of the 21st century, infectious diseases caused by RNA viruses such as SARS, pandemic influenza viruses, MERS, Zika virus, and SARS-CoV-2 have spread. When such emerging and re-emerging viruses occur and spread, it is important for public health to quickly analyze the characteristics of these viruses and develop preventive measures. We found that the Zika virus causes damage to the testes, leading to testicular atrophy; that a vaccine based on mosquito salivary gland proteins suppresses mosquito-borne Zika virus transmission/infection; that the pathogenicity of SARS-CoV-2 Omicron variants BA.
View Article and Find Full Text PDFPrevalence of culicine salivary antibodies in non-human primates living in national parks in Thailand.
Med Vet Entomol
November 2024
Department of Medical Entomology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Article Synopsis
- * A study measured the presence of antibodies to mosquito saliva in different macaque species across national parks, revealing high antibody levels, especially against the Culex quinquefasciatus species, indicating significant interaction with mosquito vectors.
- * The research highlights the potential for using mosquito saliva as a biomarker for studying host interactions and pathogen exposure, while also raising concerns about disease transmission between macaques, visitors, and mosquitoes in natural areas.
Relative efficacy of anti-Plasmodium vivax malaria combination drugs in preventing transmission to two major Anopheles mosquitoes in the first few days of treatment.
Int J Infect Dis
January 2025
Programa de Pós-Graduação em Medicina Tropical, Fundação de Medicina Tropical Heitor Vieira Dourado, Universidade do Estado do Amazonas, Manaus, Brazil; Laboratório de Entomologia Médica, Instituto de Pesquisas René Rachou, Fundação Oswaldo Cruz Minas, Belo Horizonte, Minas Gerais, Brazil. Electronic address:
Objectives: The World Health Organization recommends three drug anti-malarial combinations: cloroquine+primaquine, artesiminin+primaquine, and cloroquine+tafenoquine. These combinations aim to eradicate Plasmodium by disrupting its life cycle within the human body. We evaluated the effect of these medications on the vectorial competence of two main vectors in the New World.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!